CCR Stock Overview
Constance Care Spolka Akcyjna operates a professional center for neurological, orthopedic, and neuropsychological rehabilitation.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Constance Care Spolka Akcyjna Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł10.80 |
52 Week High | zł37.60 |
52 Week Low | zł10.60 |
Beta | 0 |
1 Month Change | -35.33% |
3 Month Change | n/a |
1 Year Change | -42.25% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -77.50% |
Recent News & Updates
Recent updates
Shareholder Returns
CCR | PL Healthcare | PL Market | |
---|---|---|---|
7D | -18.2% | 0.7% | 2.1% |
1Y | -42.2% | 49.8% | 35.7% |
Return vs Industry: CCR underperformed the Polish Healthcare industry which returned 50.8% over the past year.
Return vs Market: CCR underperformed the Polish Market which returned 34.3% over the past year.
Price Volatility
CCR volatility | |
---|---|
CCR Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 5.0% |
10% most volatile stocks in PL Market | 9.6% |
10% least volatile stocks in PL Market | 3.3% |
Stable Share Price: CCR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CCR's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | n/a | n/a | https://constancecare.pl |
Constance Care Spolka Akcyjna operates a professional center for neurological, orthopedic, and neuropsychological rehabilitation. The company provides its services for the improvement of health and life quality of patients with motor dysfunctions resulting from various accidents, diseases, and ageing. It also offers rehabilitation of cognitive functions for children and adults.
Constance Care Spolka Akcyjna Fundamentals Summary
CCR fundamental statistics | |
---|---|
Market cap | zł8.48m |
Earnings (TTM) | zł0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs CCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CCR income statement (TTM) | |
---|---|
Revenue | zł0 |
Cost of Revenue | zł0 |
Gross Profit | zł0 |
Other Expenses | zł0 |
Earnings | zł0 |
Last Reported Earnings
n/a
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CCR perform over the long term?
See historical performance and comparison